Greg Harlow is a fun-loving and hard-working PhD professional serving as the Director of Medical Diagnostics at AstraZeneca since 2024. With extensive experience in KOL/TAE management, clinical research studies, and HCP education, they possess deep knowledge of immuno-oncology, biomarkers, and checkpoint inhibitor therapies. Previously, Greg held leadership roles at Carondelet Health Network, Ventana Medical Systems, Sanofi-Aventis U.S. LLC, Array BioPharma Inc., and Agilent Technologies, contributing significantly to oncology research and medical affairs. They earned a Bachelor of Science in Biology from Northern Illinois University and a PhD in Cell/Cellular and Molecular Biology from the University of Arizona.
This person is not in the org chart
This person is not in any teams
This person is not in any offices